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Abstract
Background: Globally, pneumonia is the leading cause of morbidity and mortality in children, with the highest
burden experienced in sub-Saharan Africa and Asia. However, there is a dearth of information on the etiology of
severe acute respiratory illness (SARI) in Africa, including Niger.
Methods: We implemented a retrospective study as part of national influenza sentinel surveillance in Niger. We
randomly selected a sample of nasopharyngeal specimens collected from children <5 years of age hospitalized
with SARI from January 2010 through December 2012 in Niger. The samples were selected from individuals that
tested negative by real-time reverse transcription polymerase chain reaction (rRT-PCR) for influenza A and B virus.
The samples were analyzed using the Fast Track Diagnostic Respiratory Pathogens 21plus Kit (BioMérieux,
Luxemburg), which detects 23 respiratory pathogens including 18 viral and 5 bacterial agents.
Results: Among the 160 samples tested, 138 (86 %) tested positive for at least one viral or bacterial pathogen; in 22
(16 %) sample, only one pathogen was detected. We detected at least one respiratory virus in 126 (78 %) samples
and at least one bacterium in 102 (64 %) samples. Respiratory syncytial virus (56/160; 35 %), rhinovirus (47/160;
29 %) and parainfluenza virus (39/160; 24 %) were the most common viral pathogens detected. Among bacterial
pathogens, Streptococcus pneumoniae (90/160; 56 %) and Haemophilus influenzae type b (20/160; 12 %)
predominated.
Conclusions: The high prevalence of certain viral and bacterial pathogens among children <5 years of age with
SARI highlights the need for continued and expanded surveillance in Niger.
Keywords: Niger, Severe acute respiratory illness, Virus, Bacteria, Etiology
Background
Acute respiratory infections (ARIs) are responsible for
substantial morbidity and mortality globally, especially in
children <5 years of age, and the highest burden is ob-
served in developing nations [1]. In 2000, approximately
2.2 million ARI-associated deaths occurred among chil-
dren <5 years of age of which 70 % were in Africa and
Southeast Asia [2]. Both bacteria and viruses have been
identified as the etiological agents of ARI. The viruses
most frequently detected in children with ARIs include
respiratory syncytial virus (RSV), influenza virus (INF)
types A and B, adenovirus (AV), parainfluenza virus
(PIV), human metapneumovirus (HMPV) and rhinovirus
(RV) [3–5]; however, the clinical presentations of re-
spiratory tract infections are similar, making it difficult
to distinguish between etiologic agents without a labora-
tory diagnosis [6]. In addition, the interpretation of a
viral detection is complicated by the fact that infections
with multiple viruses are common in children with ARI
and many viruses are frequently found in asymptomatic
children [7]. Streptococcus pneumoniae and Haemophi-
lus influenzae type b (Hib) are the most commonly
isolated bacteria from ARI cases, while, other atypical
pathogens such as Mycoplasma pneumoniae and
Chlamydophila pneumoniae are less frequently reported
[8–10]. S. pneumoniae and Hib are commonly identified
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in nasopharyngeal samples from asymptomatic children
due to high rates of carriage; however, their identification
from the nasopharynx is rarely indicative of invasive dis-
ease [11].
The viral and bacterial etiology of ARI has been well
documented in countries from the Northern hemisphere
[12–15]; however, few studies are available from Africa
[16, 17]. In Niger, a sentinel surveillance system for in-
fluenza viruses was instituted in April 2009; however, no
studies on the etiology of ARI have been conducted in
the country. We aimed to document the prevalence of
selected viral and bacterial infections among children
<5 years of age hospitalized with severe acute respiratory
illness (SARI) at selected hospitals in Niger from January
2010 through December 2012.
Methods
Study design and setting
Niger is a West African country with a Saharan cli-
mate characterized by four distinct seasons: the cold
season from mid-December to mid-February, the dry
and hot season from mid-February to May, the rainy
season from June to September, and the hot season
from October to mid-December [18, 19].
Since April 2009, influenza surveillance has been
conducted among patients hospitalized with severe
acute respiratory illness (SARI) at 8 sentinel sites lo-
cated in 5 of the 8 regions of the country by the
Centre de Recherche Médicale et Sanitaire (CERMES),
the National Reference Laboratory for influenza. The
influenza surveillance program in Niger has previ-
ously been described [19]. Briefly, all patients hospi-
talized at the participating sentinel sites that met the
SARI case definition were eligible for enrollment. Ver-
bal informed consent was obtained from all cases
who were 18 years of age and older. Proxy informed
consent was obtained from parents or legal guardians
of minors. Patients who did not meet the case defin-
ition or did not provide verbal consent were not
included.
A SARI case was defined as a hospitalized child
<5 years of age with onset of cough or difficulty breath-
ing within 7 days prior to admission, and at least one of
the following danger signs: inability to drink or breast-
feed, lethargy, vomiting everything, convulsions, nasal
flaring, chest indrawing, stridor in a calm child or tach-
ypnea [20].
A standardized questionnaire was administrated by
clinical personnel, to record patients’ demographic
characteristics and medical history. The questions in-
cluded information on date of enrollment and symp-
tom onset, sex, age and clinical symptoms.
Nasopharyngeal (NP) swabs were collected from all
enrolled cases and placed in cryovials containing virus
transport medium (Copan kit, Italy). The specimens
were kept refrigerated at 4 °C at the sentinel site and
then transported twice weekly to CERMES for testing.
Samples were aliquoted, screened for influenza A and
B viruses by real-time reverse transcription polymer-
ase chain reaction (rRT-PCR), and then stored at
−80 °C.
Sampling and laboratory procedures
We conducted a retrospective study on the etiology
of influenza-negative SARI cases among children
<5 years of age enrolled in influenza surveillance
during January 2010 through December 2012 in
Niger. We randomly selected (using random selec-
tion procedures available in Stata) a sample of 160
stored NP specimens from 742 SARI cases which
had tested influenza A and B negative. This sample
represented 21 % of the total cases aged <5 years
enrolled during the study period. Only 5.5 % of
SARI cases in the <5 year old age group were tested
positive for influenza. Influenza-positive cases were
mainly detected during the cold season [21].
Nucleic acid was extracted using the QIAamp mini kit
(Qiagen, Germany) in accordance with the manufac-
turer’s protocol. An internal control (IC) was added to
each extraction tube in order to assess the quality of the
extraction at the end of the amplification. Extracted
samples were screened by rRT-PCR with Fast Track
Diagnostic (FTD) Respiratory pathogens 21plus kit (Bio-
Mérieux, Luxemburg) following the manufacturer’s pro-
cedure using six multiplex PCR for 18 viruses: influenza
(INF) types A and B, parainfluenza virus (PIV) types 1–
4, coronavirus (CV) NL63, 229E, OC43, and HKU1,
metapneumovirus A-B (HMPV), respiratory syncytial
virus A-B (RSV), parechovirus (PV), enterovirus (EV),
adenovirus (AV), human bocavirus (HBV), rhinovirus
(RV) and 5 bacterial pathogens: Mycoplasma pneumo-
niae (M. pneumoniae), Chlamydophila pneumoniae (C.
pneumoniae), Streptococcus pneumoniae (S. pneumo-
niae), Haemophilus influenzae type b (Hib), and
Staphylococcus aureus (S. aureus) [22]. Two different
positive controls for viral and bacterial multiplex PCR
reactions and a negative control tube are provided in the
kit
Statistical analysis
The Χ2 and the Fisher’s exact tests were used to as-
sess the difference between categorical variables by
comparing expected and observed frequencies across
evaluated groups. In addition, we compared the
characteristics of selected and non-selected children
(including influenza-positive cases) using the X2 sta-
tistics. The statistical analysis was implemented using
Stata version 13.1 (StataCorp®, Texas, USA).
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Ethics approval
In 2009, the National Ethics Committee of Niger ap-
proved the national influenza surveillance program (ref-
erence No06/2009/CCNE of April 2009). In 2012, prior
to the investigation of other respiratory pathogens, the
Ministry of Health provided an extended approval. Ac-
cess to the study samples was granted by the Director of
CERMES.
Results
From January 2010 through December 2012 we enrolled
785 children <5 years of age hospitalized with SARI into
the influenza surveillance program, of which 742 (94 %)
tested negative for influenza virus. Of these, 160 (21 %)
were randomly selected for our study. The age, sex and
symptom duration distribution did not differ signifi-
cantly among selected and non-selected children (in-
cluding those that tested positive for influenza).
However, among the selected group there was a signifi-
cantly lower proportion of specimens collected during
the cold season, when the majority of influenza-positive
cases were detected and excluded from randomization
(Table 1).
Among the selected children, 56 % (90/160) were
<1 year of age (median age among children age <5 years:
9 months), 46 % (73/160) were female and 78 % (125/
160) had a duration of symptoms ≤3 days. Most patients
presented with a recorded temperature >38 °C (58 %;
93/160), cough (96 %; 155/160), dyspnea (69 %; 111/160)
and chest indrawing (76 %; 122/160). Few patients pre-
sented with tachypnea or had difficulty in breastfeeding
(15 %; 25/160).
Overall, 138/160 (86 %) of children included in the
study tested positive for at least one pathogen (viral or
bacterial). At least one respiratory virus was detected in
126/160 (78 %) samples and at least one bacterium was
detected in 102/160 (64 %) samples. Among the 138
samples positive for any pathogen, 22 (16 %) were posi-
tive for a single pathogen. Of these 8 (36 %) were posi-
tive for S. pneumoniae, 4 (18 %) for RSV and 4 (18 %)
for RV, while HMPV, CV, PIV and Hib each accounted
individually for <10 % of the single organisms detected
(Fig. 1). Among the 116 children in whom ≥2 organisms
were detected, both viral and bacterial pathogens were
detected in 90 samples (78 %).
Among the 160 samples tested, RSV (n = 56; 35 %)
was the most frequently detected virus, followed by RV
(n = 47; 29 %) and PIV types 1–4 (n = 39; 24 %) (Table 2).
CV, HMPV, HBV, EV and AV were detected individually
in <15 % of the specimens. No PV was detected in our
study. Of the 20 samples that tested positive for CV, 13
(65 %) were type OC43, 9 (45 %) were type 229E, 6
(30 %) were type NL63 and 4 (20 %) were type HKU1.
Of the 39 samples that tested positive for PIV, 9 (23 %)
were type 1, 3 (8 %) were type 2, 31 (79 %) were type 3
and 21 (53 %) were type 4. Even though we selected
Table 1 Characteristics of children <5 years of age hospitalized with severe acute respiratory illness selected and non-selected for
the study in Niger, 2010–2012
Characteristics Children selected for the study Children non-selected for the studya p
n (%) n (%)
N = 160 N = 625
Age (in years) 0.811
<1 90 (56.2) 362 (57.9)
1–4 70 (43.8) 263 (42.1)
Sex 0.121
Female 7 (45.6) 243 (38.9)
Male 87 (54.4) 382 (61.1)
Duration of symptoms (in days) 0.88
0–3 125 (78.1) 524 (83.8)
4–7 35 (21.9) 101 (16.2)
Season <0.001
Hot 64 (40.0) 255 (40.8)
Cold 6 (3.7) 97 (15.5)
Rain 48 (30.0) 135 (21.6)
Dry 42 (26.3) 138 (22.1)
Abbreviations, CI confidence interval
aIncluding children that tested positive for influenza virus
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influenza A and B negative samples, we detected 2 INFA
(1.2 %) and 4 INFB positive (2.5 %) samples with the
Fast Track platform.
Co-detections with different subtypes were detected in
6 (30 %) and 20 (51 %) of the CV and PIV positive cases,
respectively. RSV, PIV and HMPV were detected more
frequently in infants <1 year of age compared to children
1–4 years of age (Table 2). RSV, PIV and HMPV were
detected more frequently during the hot season (Octo-
ber to mid-December); while RV and HBV were detected
more frequently during the rainy season (June to Sep-
tember). The other viruses were detected with similar
frequencies across seasons (Table 2).
Among the 160 samples tested, S. pneumoniae (n = 90;
56 %) was the most frequently detected bacteria,
followed by Hib (n = 20; 12 %), S. aureus (n = 18; 11 %)
and C. pneumoniae (n = 4; 2.5 %) (Table 3). M. pneumo-
niae was not detected in our study.
Discussion
We report the detection rate of selected viral and bacter-
ial pathogens among children <5 years of age hospital-
ized with SARI in Niger. We detected respiratory viruses
in 78 % of our study sample. The high detection rate of
viruses found in our study is consistent with results from
similar studies conducted in Burkina Faso (73 %) [23],
Kenya (68 %) [24] and Brazil (85 %) [12]. However, lower
rates of viral detection were reported from other studies
from countries such as Ghana (26 %) [25], China (56 %)
[26] and Egypt (60 %) [4]. These differences can be at-
tributed to different climatic conditions, enrollment cri-
teria, case definitions and testing platforms.
In our study, RSV was the predominant virus detected
and was most commonly found in children <1 year of
age. RSV has been reported to be an important pathogen
in children and especially in young infants in several
studies [12, 25–29]. In addition, RSV detection has been
reported to be strongly associated with illness from stud-
ies comparing symptomatic cases to controls [30].
Rhinovirus was the second most commonly detected
virus (29 %) with similar rates among infants <1 year of
age and children aged 1–4 years, which has been re-
ported in previous studies [31, 32]. However, other stud-
ies reported RV as the most prevalent virus among
children <5 years of age [16, 23, 28, 33]. In addition RV
has been commonly detected among asymptomatic per-
sons in several studies indicating that RV can act as both
pathogen and by-stander, consequently hindering the
ability to infer an association between detection and ill-
ness [34–36]. Among the PIV and CV detected in this
study, PIV type 3 and CV type OC43 were the most
common virus types, which has been reported in other
studies [12, 16].
We also found a high detection rate of bacterial patho-
gens. S. pneumoniae (56 %) and Hib (12 %) were the
Fig. 1 Proportion of respiratory pathogens detected in single infection
(N = 22) among children <5 years of age hospitalized with severe
acute respiratory illness in Niger, 2010–2012
Table 2 Detection of respiratory viruses among children <5 years of age hospitalized with severe acute respiratory illness in Niger,
2010–2012
Characteristics Detection rate n (%)
RV CV PIV HMPV BV RSV EV AV Any virus
Total (N = 160) 47 (29.4) 20 (12.5) 39 (24.4) 21 (13.1) 21 (13.1) 56 (35.0) 7 (4.3) 10 (6.2) 126 (78.7)
Age group p = 0.878 p = 0.718 p = 0.024 p = 0.048 p = 0.302 p <0.001 p = 0.700 p = 0.987 p = 0.006
<1 y (N = 90) 26 (28.9) 12 (13.3) 28 (31.1) 16 (17.8) 14 (15.6) 44 (48.9) 3 (3.3) 6 (6.7) 78 (86.7)
1–4 y (N = 70) 21 (30.0) 8 (11.4) 11 (15.7) 5 (7.1) 7 (10.0) 12 (17.4) 4 (5.7) 4 (5.7) 48 (68.6)
Season p <0.001 p = 0.178 p = 0.014 p = 0.049 p = 0.003 p = 0.001 p = 0.558 p = 0.581 p <0.001
Hot (N = 64) 16 (25.0) 12(18.8) 24(37.5) 14 (21.9) 10 (15.6) 34 (53.1) 2 (3.1) 6 (9.4) 56 (87.5)
Cold (N = 6) 0 (0.0) 1 (16.7) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (16.7)
Rainy (N = 48) 26 (54.2) 3 (6.2) 7 (14.6) 5 (10.4) 11(22.9) 13 (27.1) 4 (8.3) 3 (6.2) 42 (87.5)
Dry (N = 42) 5 (11.9) 4 (9.5) 8 (19.1) 2 (4.7) 0 (0.0) 9 (21.4) 1 (2.4) 1 (2.4) 27 (64.3)
Abbreviations: RV Rhinovirus, CV Coronavirus (229, 63, 43, HKU), PIV Parainfluenza virus (types 1–4), HMPV Human metapneumovirus, RSV Respiratory Syncytial
Virus, EV Enterovirus, AV Adenovirus
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most common bacteria detected in nasopharyngeal spec-
imens. Elevated colonization rates of these bacteria have
been reported in children, but only a proportion of colo-
nizations result in invasive disease [9, 11, 37]. The high
detection rate of S. pneumoniae in our study is likely
due to the fact that S. pneumoniae is a commensal of
the nasopharynx [38]. It has been shown that the preva-
lence of S. pneumoniae carriage in healthy children
<5 years of age ranges from 20 % to 93 % in low income
countries [11]. The detection of S. pneumoniae from
sterile sites like blood or cerebrospinal fluid, reflecting
invasive pneumococcal disease, has been shown to be
lower (5–9 %) [8, 39]. Nonetheless, S. pneumoniae has
been reported to be responsible for 12 % of meningitis
cases in Niger based on cerebrospinal fluid testing; 26
different serotypes were detected among cases of menin-
gitis prior to the introduction of the pneumococcal con-
jugate vaccine in 2014 [40]. Hib and S. aureus, the 2nd
and 3rd most prevalent bacterial pathogens in our study,
have also been shown to be commensal organisms with
high nasopharyngeal carriage rates especially in young
children [11]. The substantial Hib nasopharyngeal
colonization density found in this study should be inves-
tigated further as Hib vaccine has been available in the
Niger expanded immunization program since 2008.
Nasopharyngeal specimens may be used to aid in the
diagnosis of certain bacterial respiratory pathogens that
do not tend to colonize the nasopharynx, such as M.
pneumoniae and C. pneumoniae [38, 41]. C. pneumoniae
was detected at low rates (2.5 %), and M. pneumoniae
was not detected in our study. Using serological
methods, prevalence rates as high as 30 % have been re-
ported for C. pneumoniae [9]; in contrast, other studies
report significant detection of M. pneumoniae (>10 %)
and low detection of C. pneumoniae (<1 %) [12, 26, 42].
In our study we found an elevated prevalence (78 %)
of viral–bacterial co-detections, which has been reported
in other studies [12, 42]. It has been shown that viral
infections may predispose to bacterial super-infection by
favoring bacterial attachment sites on nasopharyngeal
epithelial cells and through increased mucous produc-
tion that promotes bacterial growth [38, 42].
Our study has limitations that warrant discussion.
First, the small sample size of our study hindered our
ability to accurately assess the seasonality of the patho-
gens included in our study. Nonetheless, our results sug-
gest that RSV, PIV and HMPV are more commonly
detected during the hot season (October to December),
while RV and HBV are detected more frequently during
the rainy season (June to September). No difference in
the detection rate of the other viruses and bacteria was
noted across seasons in our study. The small sample size
of our study also hindered our ability to detect patterns
of co-detection and the association between specific viral
and bacterial co-detections. Second, we did not keep for-
mal records of the proportion of patients consenting to
participate in the SARI surveillance. However, a review
of the performance of the surveillance system imple-
mented through hospital record review at sentinel sites
revealed that only a few patients that met the study case
definition were missed by the surveillance program.
Third, the lack of controls in our study limited our abil-
ity to assess the association of pathogen detection with
disease. While most of the viral and bacterial pathogens
identified in this study have been described by previous
studies as causative agents of ARI, the assignation of
causality remains challenging [39, 43]. Fourth, influenza-
positive samples were excluded from our study. Co-
detection of other viral and bacterial pathogens with in-
fluenza is expected and this may have resulted in an
underestimation of the prevalence of the pathogens in-
cluded in this study, especially during the cold season
when the majority of influenza-positive cases were de-
tected. Last, we did not systematically collect informa-
tion on progression of illness (including in-hospital
outcome) or risk factors for severe disease, which
Table 3 Detection of respiratory bacteria among children <5 years of age hospitalized with severe acute respiratory illness in Niger,
2010–2012
Characteristics Detection rate n (%)
C. pneumoniae S. aureus H. influenzae type b S. pneumoniae Any bacteria
Total (N = 160) 4 (2.5) 18 (11.3) 20 (12.5) 90 (56.3) 102 (63.7)
Age group p = 0.632 p = 0.659 p = 0.117 p = 0.602 p = 0.431
<1 y (N = 90) 3 (3.3) 11 (12.2) 8 (8.9) 49 (54.4) 55 (61.1)
1-4 y (N = 70) 1 (1.4) 7 (10.0) 12 (17.1) 41 (58.6) 47 (67.1)
Season p = 0.467 p = 0.976 p = 0.245 p = 0.579 p = 0.748
Hot (N = 64) 3 (4.7) 8 (12.5) 7 (10.4) 38 (59.4) 42 (65.6)
Cold (N = 6) 0 (0.0) 0 (0.0) 0 (0.0) 3 (50.0) 3 (50.0)
Rainy (N = 48) 0 (0.0) 5 (10.4) 4 (8.3) 29 (60.4) 32 (66.7)
Dry (N = 42) 1 (2.4) 5 (11.9) 9 (21.4) 20 (47.6) 25 (59.5)
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hindered our ability to evaluate pathogen contribution
to the more severe spectrum of illness or to identify
groups at high risk for severe disease.
Conclusion
This study reports the detection rate of viral and bacter-
ial pathogens among children <5 years of age hospital-
ized with SARI in Niger. The high prevalence of certain
viral and bacterial pathogens highlights the need for ex-
panded surveillance in Niger so as to inform policies
and interventions. Given the high RSV detection rate
observed in this study and the reported association of
RSV detection with illness [30], RSV should be included
in routine surveillance programs in Niger. Other se-
lected pathogens could be considered for routine sur-
veillance in the country following further assessment to
determine association with illness. In addition, informa-
tion on progression of illness, including in-hospital out-
come and risk factors for severe disease should be
collected routinely through the existing surveillance
system.
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